Introduction: Eisenmenger syndrome (ES) is the most advanced form of pulmonary arterial
hypertension (PAH) in patients with congenital heart disease (CHD). It is characterised by a …

Eisenmenger syndrome (ES) represents the most severe phenotype of pulmonary arterial
hypertension (PAH) associated with congenital heart disease (CHD) and occurs in patients …

The presence of pulmonary arterial hypertension (PAH) increases morbidity and reduces
survival in patients with congenital heart disease (CHD). PAH-CHD is a heterogeneous …

Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension
(PAH) associated with congenital heart disease, is a devastating condition that has a …

Objective—Pulmonary arterial hypertension (PAH), associated with congenital heart disease
(CHD), usually results from a systemic-to-pulmonary shunt. Eisenmenger syndrome (ES) is …

The number of patients with pulmonary arterial hypertension related to congenital heart
disease (PAH‐CHD) seen in specialist centers continues to increase. The extreme end of …

Pulmonary arterial hypertension (PAH) is an uncommon but serious disease characterized
by severe pulmonary vascular disease and significant morbidity and mortality. PAH …

Eisenmenger syndrome (ES) is the most severe form of pulmonary arterial hypertension
(PAH) related to congenital heart disease (CHD). It results from a cardiac defect allowing …

Congenital heart disease (CHD), the most common inborn defect, affects approximately 1%
of all newborns worldwide. Advances in its diagnosis and treatment have led to a dramatic …

Eisenmenger's syndrome (ES) is the most advanced form of pulmonary arterial hypertension
(PAH) associated with congenital heart diseases (CHD). It is caused by simple or complex …